These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 29262883

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data.
    Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M.
    J Clin Oncol; 2010 Aug 20; 28(24):3866-71. PubMed ID: 20644086
    [Abstract] [Full Text] [Related]

  • 24. Realgar-indigo naturalis formula for the treatment of patients with relapsed and arsenic trioxide-resistant acute promyelocytic leukemia: A case series.
    Fang YG, Huang SL, Chen NN.
    J Integr Med; 2024 Sep 20; 22(5):614-620. PubMed ID: 39183097
    [Abstract] [Full Text] [Related]

  • 25. Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
    Ghavamzadeh A, Alimoghaddam K, Rostami S, Ghaffari SH, Jahani M, Iravani M, Mousavi SA, Bahar B, Jalili M.
    J Clin Oncol; 2011 Jul 10; 29(20):2753-7. PubMed ID: 21646615
    [Abstract] [Full Text] [Related]

  • 26. Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide.
    Shen Y, Fu YK, Zhu YM, Lou YJ, Gu ZH, Shi JY, Chen B, Chen C, Zhu HH, Hu J, Zhao WL, Mi JQ, Chen L, Zhu HM, Shen ZX, Jin J, Wang ZY, Li JM, Chen Z, Chen SJ.
    EBioMedicine; 2015 Jun 10; 2(6):563-71. PubMed ID: 26285909
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group.
    Huang DP, Yang LC, Chen YQ, Wan WQ, Zhou DH, Mai HR, Li WL, Yang LH, Lan HK, Chen HQ, Guo BY, Zhen ZJ, Liu RY, Chen GH, Feng XQ, Liang C, Wang LN, Li Y, Luo JS, Fan Z, Luo XQ, Li B, Tang YL, Zhang XL, Huang LB.
    Blood Cancer J; 2023 Dec 05; 13(1):178. PubMed ID: 38052803
    [Abstract] [Full Text] [Related]

  • 28. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y, Suo S, Tong H, Ye X, Wang Y, Chen Z, Qian W, Meng H, Mai W, Huang J, Tong Y, Jin J.
    Leuk Res; 2013 Nov 05; 37(11):1451-6. PubMed ID: 23958062
    [Abstract] [Full Text] [Related]

  • 29. Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
    Lou Y, Suo S, Tong Y, Tong H, Qian W, Meng H, Mai W, Huang J, Yu W, Jin J.
    Ann Hematol; 2014 Jun 05; 93(6):941-8. PubMed ID: 24408159
    [Abstract] [Full Text] [Related]

  • 30. [Relationship between the Therapeutic Dose of Arsenic Trioxide and Relapse in Acute Promyelocytic Leukemia].
    Wang HY, Zhang HY, Liu Y, Zhang XX, Gong S, Chen LM, Wang MC, Xi JY, Liu X.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun 05; 26(3):705-709. PubMed ID: 29950207
    [Abstract] [Full Text] [Related]

  • 31. Long-term remission after first-line single-agent treatment with arsenic trioxide of relapsed acute promyelocytic leukemia in an 8-year-old boy.
    Ebinger M, Schwarze CP, Feuchtinger T, Scheel-Walter HG, Lang P, Hildenbrand S, Gessler P, Handgretinger R.
    Pediatr Hematol Oncol; 2011 May 05; 28(4):334-7. PubMed ID: 21345080
    [Abstract] [Full Text] [Related]

  • 32. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF, Australasian Leukaemia and Lymphoma Group.
    Lancet Haematol; 2015 Sep 05; 2(9):e357-66. PubMed ID: 26685769
    [Abstract] [Full Text] [Related]

  • 33. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
    Shepshelovich D, Oniashvili N, Parnes D, Klein A, Muchtar E, Yeshaya J, Aviram A, Rabizadeh E, Raanani P.
    Cancer Genet; 2015 Nov 05; 208(11):575-9. PubMed ID: 26471811
    [Abstract] [Full Text] [Related]

  • 34. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.
    Mathews V, George B, Lakshmi KM, Viswabandya A, Bajel A, Balasubramanian P, Shaji RV, Srivastava VM, Srivastava A, Chandy M.
    Blood; 2006 Apr 01; 107(7):2627-32. PubMed ID: 16352810
    [Abstract] [Full Text] [Related]

  • 35. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Lengfelder E, Hofmann WK, Nowak D.
    Leukemia; 2012 Mar 01; 26(3):433-42. PubMed ID: 21904379
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy Analysis of Arsenic Trioxide Combined with All Trans Retinoic Acid for Acute Promyelocytic Leukemia].
    Wang LL, Ren YQ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct 01; 23(5):1292-5. PubMed ID: 26524025
    [Abstract] [Full Text] [Related]

  • 37. [Clinical investigation of homoharringtonine in combination with all-transretinoic acid and arsenic trioxide for acute promyelocytic leukemia].
    Pei RZ, Li SY, Zhang PS, Ma JX, Liu XH, Du XH, Chen D, Sha KY, Chen LG, Cao JJ, Zhuang XX, Wu JY, Lin L, Fan Z, Ye PP, Tang SH, Zhang BB, Shi XW.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb 01; 34(2):144-8. PubMed ID: 23611222
    [Abstract] [Full Text] [Related]

  • 38. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
    Lachaine J, Mathurin K, Barakat S, Couban S.
    Eur J Haematol; 2015 Sep 01; 95(3):218-29. PubMed ID: 25354894
    [Abstract] [Full Text] [Related]

  • 39. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.
    Carmosino I, Latagliata R, Avvisati G, Breccia M, Finolezzi E, Lo Coco F, Petti MC.
    Haematologica; 2004 May 01; 89(5):615-7. PubMed ID: 15136230
    [Abstract] [Full Text] [Related]

  • 40. Insights into the All-trans-Retinoic Acid and Arsenic Trioxide Combination Treatment for Acute Promyelocytic Leukemia: A Meta-Analysis.
    Ma H, Yang J.
    Acta Haematol; 2015 May 01; 134(2):101-8. PubMed ID: 25925330
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.